Zobrazeno 1 - 10
of 101
pro vyhledávání: '"cytokine-induced killer (CIK) cells"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Although allogeneic hematopoietic cell transplantation (HCT) represents a curative approach for many patients with hematological diseases, post-transplantation relapse occurs in 20-50% of cases, representing the primary cause of treatment failure and
Externí odkaz:
https://doaj.org/article/ad6aed26b47246a19c50bfae3518e995
Autor:
Gaia Alberti, Corinne Arsuffi, Alice Pievani, Domenico Salerno, Francesco Mantegazza, Francesco Dazzi, Andrea Biondi, Sarah Tettamanti, Marta Serafini
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
In acute myeloid leukemia (AML), malignant stem cells hijack the normal bone marrow niche where they are largely protected from the current therapeutic approaches. Thus, eradicating these progenitors is the ultimate challenge in the treatment of this
Externí odkaz:
https://doaj.org/article/693cec58a41b476bba4843a54cfe5697
Autor:
Xiaolong Wu, Amit Sharma, Johannes Oldenburg, Hans Weiher, Markus Essler, Dirk Skowasch, Ingo G. H. Schmidt-Wolf
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Cytokine-induced killer (CIK) cells are an ex vivo expanded heterogeneous cell population with an enriched NK-T phenotype (CD3+CD56+). Due to the convenient and relatively inexpensive expansion capability, together with low incidence of graft versus
Externí odkaz:
https://doaj.org/article/b6cb359295e6480ea386c169e5f94792
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Treatment with a combination of programmed cell death-1 (PD-1) blocker and cytokine-induced killer (CIK) cells has improved outcome in cancer patients but is also associated with various patterns of responses. Pseudoprogression is a unique and uncomm
Externí odkaz:
https://doaj.org/article/8c48d964c0b44daca4f2619a8fb70170
Autor:
S Timalsena, P P Lamichhane
Publikováno v:
Journal of Gandaki Medical College, Vol 10, Iss 2, Pp 58-63 (2018)
Cytokine induced killer (CIK) cells has been increasingly used in adoptive immunotherapy against various cancers and viral infections. This review summarizes the basic overview of CIK cells as a therapeutic immunocyte. Herein, the basic concepts on C
Externí odkaz:
https://doaj.org/article/37b197113d6247189095b4209088afb4
Autor:
Alberti G., Arsuffi C., Pievani A., Salerno D., Mantegazza F., Dazzi F., Biondi A., Tettamanti S., Serafini M.
Publikováno v:
Frontiers in Immunology. 14
In acute myeloid leukemia (AML), malignant stem cells hijack the normal bone marrow niche where they are largely protected from the current therapeutic approaches. Thus, eradicating these progenitors is the ultimate challenge in the treatment of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759c4de0a6ba867638c67ae59270cc72
https://doi.org/10.3389/fimmu.2023.1192333
https://doi.org/10.3389/fimmu.2023.1192333
Autor:
Katia Mareschi, Aloe Adamini, Sara Castiglia, Deborah Rustichelli, Laura Castello, Alessandra Mandese, Marco Leone, Giuseppe Pinnetta, Giulia Mesiano, Ivana Ferrero, Franca Fagioli
Publikováno v:
Pharmaceuticals, Vol 13, Iss 5, p 93 (2020)
Cytokine-induced killer (CIK) cells are advanced therapy medicinal products, so their production and freezing process has to be validated before their clinical use, to verify their stability as a drug formulation according to the good manufacturing p
Externí odkaz:
https://doaj.org/article/1cd2b7c216af419babe79916e49437ff
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jialing WANG, Zhe ZHANG, Sa LIU, Yunfeng YANG, Ying HE, Yuan ZHANG, Tuya WULAN, Hui ZHANG, Weili DU, Shiyong WANG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 13, Iss 4, Pp 277-281 (2010)
Background and objective The CIK cell is one of the most important means of the adoptive cellular immunotherapy, and it is a hotspot of which to simplify its culture procedure and to promote its inhibition rate. The aim of this study is to observe th
Externí odkaz:
https://doaj.org/article/fe6b7ef93c064d458d674f1441780f25
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Treatment with a combination of programmed cell death-1 (PD-1) blocker and cytokine-induced killer (CIK) cells has improved outcome in cancer patients but is also associated with various patterns of responses. Pseudoprogression is a unique and uncomm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335a5745372ef4a39a609d73ff754708
https://www.frontiersin.org/articles/10.3389/fonc.2021.640447/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.640447/full